GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Japan Lifeline Co Ltd (OTCPK:JLFNF) » Definitions » Debt-to-EBITDA

Japan Lifeline Co (Japan Lifeline Co) Debt-to-EBITDA : 0.35 (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Japan Lifeline Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Japan Lifeline Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $27.6 Mil. Japan Lifeline Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.3 Mil. Japan Lifeline Co's annualized EBITDA for the quarter that ended in Dec. 2023 was $82.4 Mil. Japan Lifeline Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.35.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Japan Lifeline Co's Debt-to-EBITDA or its related term are showing as below:

JLFNF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.37   Med: 0.89   Max: 3.07
Current: 0.42

During the past 13 years, the highest Debt-to-EBITDA Ratio of Japan Lifeline Co was 3.07. The lowest was 0.37. And the median was 0.89.

JLFNF's Debt-to-EBITDA is ranked better than
72.56% of 430 companies
in the Medical Devices & Instruments industry
Industry Median: 1.235 vs JLFNF: 0.42

Japan Lifeline Co Debt-to-EBITDA Historical Data

The historical data trend for Japan Lifeline Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Japan Lifeline Co Debt-to-EBITDA Chart

Japan Lifeline Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.96 1.63 0.69 0.59 0.37

Japan Lifeline Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.45 0.45 0.35 0.56

Competitive Comparison of Japan Lifeline Co's Debt-to-EBITDA

For the Medical Devices subindustry, Japan Lifeline Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Japan Lifeline Co's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Japan Lifeline Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Japan Lifeline Co's Debt-to-EBITDA falls into.



Japan Lifeline Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Japan Lifeline Co's Debt-to-EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(26.138 + 3.825) / 80.577
=0.37

Japan Lifeline Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(27.559 + 1.285) / 82.372
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Japan Lifeline Co  (OTCPK:JLFNF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Japan Lifeline Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Japan Lifeline Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Japan Lifeline Co (Japan Lifeline Co) Business Description

Traded in Other Exchanges
Address
2-2-20, Higashishinagawa, Tennoz Ocean Square, 25th Floor, Shinagawa-ku, Tokyo, JPN, 140-0002
Japan Lifeline Co Ltd is a medical device company operating in Japan. It is engaged in the trading and manufacturing of medical devices specialized in the cardiovascular field. The company offers medical devices mainly for the treatment of cardiac and vascular diseases. It focuses on providing implantable devices to treat arrhythmias; disposable catheter devices with electrodes for diagnosis and treatment of arrhythmias; prosthetic devices to replace blood vessels and heart valves that lost their functions; and devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities and congenital cardiac diseases.

Japan Lifeline Co (Japan Lifeline Co) Headlines

From GuruFocus